Form D · Biotechnology

FibRx Derm, Inc.

Berkeley, CA · CIK 0001764872

Offering snapshot reported May 14, 2020 · SEC filing

Reported sold
$4.2M
Offering amount: $6.75M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 3, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.1M$4.2MJan 15, 2019: $1,750,000.00Jan 15, 2019May 14, 2020: $4,200,000.00May 14, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,750,000 → $4,200,000
  • Reported investors2 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 14, 2020Amendment$4,200,000$2,450,000vs Jan 15, 20195SEC filing
Jan 15, 2019Initial$1,750,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-330595

Source: Form D, filed May 14, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark De Souza Director, Executive
James W. Fordyce Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
904 Alvarado Road
Berkeley, CA, 94705